FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090911734> ?p ?o ?g. }

• W2090911734 endingPage "484" @default.
• W2090911734 startingPage "475" @default.
• W2090911734 abstract "It has been reported that benzylamine reduces blood glucose in rabbits, stimulates hexose uptake, and inhibits lipolysis in mouse, rabbit, and human adipocytes. In the presence of vanadate, benzylamine is also able to improve glucose disposal in normoglycaemic and diabetic rats. Such insulin-mimicking properties are the consequence of hydrogen peroxide production during benzylamine oxidation by semicarbazide-sensitive amine oxidase (SSAO). The aim of the study was to determine whether other SSAO-substrates could share such potential antidiabetic properties. Thus, mafenide, a synthetic antimicrobial sulfonamide structurally related to benzylamine, and which has been recently reported to interact with SSAO, was tested in the above mentioned models, in parallel with methylamine, a proposed endogenous SSAO-substrate. All tested amines stimulated glucose uptake and inhibited lipolysis in rat and mouse fat cells. Methylamine and benzylamine, but not mafenide, reduced the hyperglycaemic response during a glucose tolerance test in rabbits while the three amines tested were devoid of insulin-releasing activity under both in vivo and in vitro conditions. In human adipocytes, mafenide did not stimulate glucose transport since it was not a high-affinity substrate for SSAO and generated less hydrogen peroxide than benzylamine or methylamine. Therefore, mafenide could not be considered as an antidiabetic drug despite being oxidized and exhibiting insulin-mimicking effects in rat and mouse adipocytes. By contrast, the endogenous substrate methylamine improved glucose utilization in all in vitro and in vivo models, leading to consider novel SSAO substrates as drugs with potential anti-hyperglycaemic properties." @default.
• W2090911734 created "2016-06-24" @default.
• W2090911734 creator A5016379031 @default.
• W2090911734 creator A5016683145 @default.
• W2090911734 creator A5020011096 @default.
• W2090911734 creator A5021038349 @default.
• W2090911734 creator A5022029177 @default.
• W2090911734 creator A5025514064 @default.
• W2090911734 creator A5060714125 @default.
• W2090911734 creator A5082844511 @default.
• W2090911734 creator A5086894543 @default.
• W2090911734 creator A5088946409 @default.
• W2090911734 date "2005-12-01" @default.
• W2090911734 modified "2023-10-01" @default.
• W2090911734 title "Methylamine but not mafenide mimics insulin-like activity of the semicarbazide-sensitive amine oxidase-substrate benzylamine on glucose tolerance and on human adipocyte metabolism" @default.
• W2090911734 cites W1532997663 @default.
• W2090911734 cites W1601399472 @default.
• W2090911734 cites W1773423156 @default.
• W2090911734 cites W1964010849 @default.
• W2090911734 cites W1969342595 @default.
• W2090911734 cites W1971537197 @default.
• W2090911734 cites W1981089957 @default.
• W2090911734 cites W1992561979 @default.
• W2090911734 cites W1996428972 @default.
• W2090911734 cites W2005044065 @default.
• W2090911734 cites W2008404887 @default.
• W2090911734 cites W2008878409 @default.
• W2090911734 cites W2026906562 @default.
• W2090911734 cites W2030338002 @default.
• W2090911734 cites W2039762060 @default.
• W2090911734 cites W2049736830 @default.
• W2090911734 cites W2053643506 @default.
• W2090911734 cites W2053798303 @default.
• W2090911734 cites W2055057067 @default.
• W2090911734 cites W2059511498 @default.
• W2090911734 cites W2064595037 @default.
• W2090911734 cites W2070506415 @default.
• W2090911734 cites W2073744019 @default.
• W2090911734 cites W2080396851 @default.
• W2090911734 cites W2085453780 @default.
• W2090911734 cites W2095816295 @default.
• W2090911734 cites W2109814312 @default.
• W2090911734 cites W2116587224 @default.
• W2090911734 cites W2117303030 @default.
• W2090911734 cites W2123369988 @default.
• W2090911734 cites W2135196923 @default.
• W2090911734 cites W2165139442 @default.
• W2090911734 cites W2166946563 @default.
• W2090911734 cites W2168100686 @default.
• W2090911734 cites W2171968999 @default.
• W2090911734 cites W81056946 @default.
• W2090911734 cites W1964905354 @default.
• W2090911734 doi "https://doi.org/10.1016/j.phrs.2005.07.008" @default.
• W2090911734 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16135411" @default.
• W2090911734 hasPublicationYear "2005" @default.
• W2090911734 type Work @default.
• W2090911734 sameAs 2090911734 @default.
• W2090911734 citedByCount "27" @default.
• W2090911734 countsByYear W20909117342012 @default.
• W2090911734 countsByYear W20909117342013 @default.
• W2090911734 countsByYear W20909117342014 @default.
• W2090911734 countsByYear W20909117342016 @default.
• W2090911734 countsByYear W20909117342017 @default.
• W2090911734 countsByYear W20909117342019 @default.
• W2090911734 countsByYear W20909117342020 @default.
• W2090911734 countsByYear W20909117342022 @default.
• W2090911734 countsByYear W20909117342023 @default.
• W2090911734 crossrefType "journal-article" @default.
• W2090911734 hasAuthorship W2090911734A5016379031 @default.
• W2090911734 hasAuthorship W2090911734A5016683145 @default.
• W2090911734 hasAuthorship W2090911734A5020011096 @default.
• W2090911734 hasAuthorship W2090911734A5021038349 @default.
• W2090911734 hasAuthorship W2090911734A5022029177 @default.
• W2090911734 hasAuthorship W2090911734A5025514064 @default.
• W2090911734 hasAuthorship W2090911734A5060714125 @default.
• W2090911734 hasAuthorship W2090911734A5082844511 @default.
• W2090911734 hasAuthorship W2090911734A5086894543 @default.
• W2090911734 hasAuthorship W2090911734A5088946409 @default.
• W2090911734 hasConcept C117001961 @default.
• W2090911734 hasConcept C134018914 @default.
• W2090911734 hasConcept C140985366 @default.
• W2090911734 hasConcept C150903083 @default.
• W2090911734 hasConcept C171089720 @default.
• W2090911734 hasConcept C178790620 @default.
• W2090911734 hasConcept C181199279 @default.
• W2090911734 hasConcept C185592680 @default.
• W2090911734 hasConcept C18903297 @default.
• W2090911734 hasConcept C207001950 @default.
• W2090911734 hasConcept C2776175234 @default.
• W2090911734 hasConcept C2776276205 @default.
• W2090911734 hasConcept C2777289219 @default.
• W2090911734 hasConcept C2778969155 @default.
• W2090911734 hasConcept C2779306644 @default.
• W2090911734 hasConcept C55493867 @default.
• W2090911734 hasConcept C86803240 @default.
• W2090911734 hasConceptScore W2090911734C117001961 @default.
• W2090911734 hasConceptScore W2090911734C134018914 @default.
• W2090911734 hasConceptScore W2090911734C140985366 @default.

• next